UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.565

Sortiert nach

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

International journal of clinical practice (Esher), 2010-04, Vol.64 (5), p.562-576

2010

Link zum Volltext

Verfügbarkeit prüfen

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.984-990

2010

Link zum Volltext

Verfügbarkeit prüfen

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

International Journal of Obesity, 2010-05, Vol.34 (5), p.919-935

2010

Link zum Volltext

Verfügbarkeit prüfen

clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

International Journal of Obesity, 2010-08, Vol.34 (8), p.1243-1254

2010

Link zum Volltext

Verfügbarkeit prüfen

Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

Diabetes, obesity & metabolism, 2013-12, Vol.15 (12), p.1101-1110

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-02, Vol.65 (2), p.154-164

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-09, Vol.65 (9), p.930-938

2011

Link zum Volltext

Verfügbarkeit prüfen

Finasteride increases anagen hair in men with androgenetic alopecia

British journal of dermatology (1951), 2000-10, Vol.143 (4), p.804-810

2000

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

Diabetes, obesity & metabolism, 2011-02, Vol.13 (2), p.160-168

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-02, Vol.12 (2), p.167-177

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-05, Vol.12 (5), p.442-451

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-03, Vol.12 (3), p.252-261

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.498-504

2011

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

Diabetes, obesity & metabolism, 2008-07, Vol.10 (7), p.545-555

2008

Link zum Volltext

Verfügbarkeit prüfen

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.644-652

2011

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men

Dermatologic surgery, 1998-12, Vol.24 (12), p.1330-1332

1998

Link zum Volltext

Verfügbarkeit prüfen

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

Biochemical and biophysical research communications, 1989-12, Vol.165 (3), p.1184-1190

1989

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Diabetes, obesity & metabolism, 2014-03, Vol.16 (3), p.223-230

2014

Link zum Volltext

Verfügbarkeit prüfen

ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA

Dermatologic clinics, 1996-10, Vol.14 (4), p.697-711

Kaufman, Keith D.

1996

Link zum Volltext

Verfügbarkeit prüfen

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.67-76

2012

Link zum Volltext

Verfügbarkeit prüfen

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Diabetes, obesity & metabolism, 2011-09, Vol.13 (9), p.841-849

2011

Link zum Volltext

Verfügbarkeit prüfen

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

International journal of clinical practice (Esher), 2015-06, Vol.69 (6), p.626-631

2015

Link zum Volltext

Verfügbarkeit prüfen

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-05, Vol.14 (5), p.409-418

2012

Link zum Volltext

Verfügbarkeit prüfen

CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN

The Journal of urology, 1999-10, Vol.162 (4), p.1295-1300

1999

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study

Diabetes, obesity & metabolism, 2012-08, Vol.14 (8), p.745-752

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.565

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.318)
Mit Volltextzugriff
(2.204)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.642)
Life Sciences & Biomedicine
(1.368)
Humans
(1.216)
Female
(778)
Male
(722)
Biological And Medical Sciences
(662)
Medical Sciences
(567)
Adult
(461)
Middle Aged
(454)
Aged
(314)
Animals
(279)
Adolescent
(236)
Physical Sciences
(219)
Child
(173)
Treatment Outcome
(172)
Physics
(162)
Surgery
(156)
Oncology
(151)
Risk Factors
(148)
Fundamental And Applied Biological Sciences. Psychology
(123)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

Finasteride increases anagen hair in men with androgenetic alopecia

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN

Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study

Suchergebnisse filtern